Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO).

Find the best route to your compound!

Spaya uses Artificial Intelligence to discover and prioritize synthetic routes.

Spaya retrosynthesis AI engine available through an API in a scalable infrastructure, enabling high throughput synthetic accessibility scoring of virtual molecules libraries